comparemela.com

Latest Breaking News On - Department of medicine - Page 2 : comparemela.com

Trodelvy Improves Quality of Life Over Chemo in TNBC

Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.

United-states
American
Aditya-bardia
Health-jonsson-comprehensive-cancer-center
Department-of-medicine
American-society-of-clinical-oncology-annual-meeting
Translational-research-integration
Drug-administration
Clinical-oncology-annual
Jonsson-comprehensive-cancer

Biosimilars Month in Review: May 2024

The biosimilars month in review highlights recent FDA approvals and successful comparison trials.

United-kingdom
Japan
Clare-harris
Adalimumab-biosimilars
Boehringer-ingelheim
Stephenb-hanauer
Stephen-pagnotta
Division-of-gastroenterology
Northwestern-university
Feinberg-school-of-medicine
Drug-administration
Department-of-medicine

Low on memory, attention? Blame vitamin B12 deficiency, hyperthyroidism

Low on memory, attention? Blame vitamin B12 deficiency, hyperthyroidism
indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.

New-delhi
Delhi
India
Indraprastha
Haryana
Hyderabad
Andhra-pradesh
Sudhir-kumar
Department-of-medicine
Senior-consultant
Sir-ganga-ram-hospital
Indraprastha-apollo-hospitals

Dr Hernandez-Ilizaliturri on the Implications of the FDA Approval of Liso-Cel for R/R Follicular Lymphoma

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Francisco-hernandez-ilizaliturri
Department-of-immunology
Biomedical-sciences
Lymphoma-research
Lymphoma-translational-research-lab
Jacobs-school-of-medicine
University-at-buffalo
Roswell-park-comprehensive-cancer-center
Department-of-medicine
Jacobs-school

Dr Foldi on T-DXd and Sacituzumab Govitecan in Metastatic Breast Cancer

Julia Foldi, MD, PhD, discusses the utility of of T-DXd and sacituzumab govitecan in the treatment of metastatic HER2-low and triple-negative breast cancer.

Julia-foldi
Hillman-cancer-center
Department-of-medicine
University-of-pittsburg-medical-center
Pittsburg-medical-center
Cancer-center

vimarsana © 2020. All Rights Reserved.